178 Participants Needed

Virtual Care for Heart Failure

Recruiting at 6 trial locations
KC
Overseen ByKrista Camuglia
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to evaluate how safe and effective a remote, digital intervention is that helps clinicians use and optimally adjust heart failure medications, compared to usual care medication use and adjustment, in participants with heart failure with reduced ejection fraction

Who Is on the Research Team?

AD

Adam DeVore, MD

Principal Investigator

Duke University

Are You a Good Fit for This Trial?

This trial is for adults over 18 with heart failure and reduced ejection fraction (LVEF <40%) who have access to a smartphone. It's not for those in hospice care, pregnant, on certain heart failure therapies deemed optimal by the investigator, living in assisted facilities, using chronic IV heart medications, with prior heart transplants or severe kidney issues.

Inclusion Criteria

I am older than 18 years.
I have heart failure with a heart function (LVEF) less than 40%.
Fluent in written and spoken English
See 2 more

Exclusion Criteria

You currently have or are planning to get a left ventricular assist device.
Current pregnancy
I regularly use medications like milrinone, dobutamine, or dopamine through an IV.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a remote, digital intervention to help clinicians use and optimally adjust heart failure medications

6 months
Remote monitoring with daily vital signs reporting

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Digital Heart Failure Medication Titration
Trial Overview The VITAL-HF study tests a digital intervention that helps doctors adjust heart failure medications remotely against usual care methods. The goal is to see if this virtual approach can safely improve outcomes for patients with reduced ejection fraction.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Digital Heart Failure Medication TitrationExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Duke University

Lead Sponsor

Trials
2,495
Recruited
5,912,000+

Story Health Inc.

Collaborator

Trials
1
Recruited
180+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security